|
|
Volumn 13, Issue 9, 2004, Pages 615-619
|
|
Post marketing surveillance of buprenorphine
a
|
|
Author keywords
Adverse effects; Buprenorphine; Post marketing surveillance
|
|
Indexed keywords
ADDNOK;
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
BUPRENORPHINE;
CREATININE;
ILLICIT DRUG;
METHADONE;
OPIATE;
OPIATE AGONIST;
OPIATE ANTAGONIST;
UREA;
ABDOMINAL PAIN;
ADULT;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ANALGESIA;
ANGER;
ANOREXIA;
ANXIETY DISORDER;
ARTICLE;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
CARDIOVASCULAR DISEASE;
CHILL;
CLINICAL OBSERVATION;
CONSTIPATION;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DIASTOLIC BLOOD PRESSURE;
DIZZINESS;
DROWSINESS;
DRUG FATALITY;
DRUG INTOXICATION;
DRUG MARKETING;
DRUG SURVEILLANCE PROGRAM;
DYSPNEA;
EMOTIONAL DISORDER;
EPISTAXIS;
EUPHORIA;
FEVER;
FLATULENCE;
HEADACHE;
HEALTH CARE FACILITY;
HUMAN;
HYPERTENSION;
INCREASED APPETITE;
INDIA;
INSOMNIA;
JAUNDICE;
KIDNEY DYSFUNCTION;
LABORATORY TEST;
LACRIMATION;
LIBIDO DISORDER;
LIVER DYSFUNCTION;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
MEDICAL DOCUMENTATION;
MUSCLE CRAMP;
MUSCLE WEAKNESS;
MYALGIA;
OPIATE ADDICTION;
PANIC;
PREMATURE EJACULATION;
PRIORITY JOURNAL;
SEIZURE;
SEXUAL FUNCTION;
SIDE EFFECT;
SYMPTOMATOLOGY;
SYSTOLIC HYPERTENSION;
TABLET FORMULATION;
TACHYPNEA;
UREA BLOOD LEVEL;
VISUAL IMPAIRMENT;
VOMITING;
WITHDRAWAL SYNDROME;
XEROSTOMIA;
YAWNING;
ADMINISTRATION, SUBLINGUAL;
ADULT;
BUPRENORPHINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
NARCOTIC ANTAGONISTS;
NAUSEA;
PRODUCT SURVEILLANCE, POSTMARKETING;
RECEPTORS, OPIOID;
SLEEP STAGES;
SUBSTANCE-RELATED DISORDERS;
TABLETS;
VOMITING;
|
|
EID: 4644356513
PISSN: 10538569
EISSN: None
Source Type: Journal
DOI: 10.1002/pds.975 Document Type: Article |
|
Times cited : (15)
|
|
References (10)
|
